Orally Bioavailable Anti-HBV Dinucleotide Acyloxyalkyl Prodrugs


Coughlin, J. E., Padmanabhan, S., Zhang, G., Kirk, C. J., Govardhan, C. P., Korba, B. E., … & Iyer, R. P. (2010). Orally bioavailable anti-HBV dinucleotide acyloxyalkyl prodrugs. Bioorganic & medicinal chemistry letters, 20(5), 1783-1786.


The acyloxyalkyl derivatives of a model anti-HBV dinucleotide were synthesized and evaluated as orally bioavailable prodrugs. Our studies have led to the identification of the first orally bioavailable dinucleotide prodrugs for further therapeutic development against the hepatitis B virus (HBV).

Read more from SRI